LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDY
单位:[1]Peking University People’s Hospital, Beijing[2] Hangzhou First People’s Hospital, Hangzhou[3] The Second Xiangya Hospital of Central South University, Changsha[4] The First Hospital of China Medical University, Shenyang[5] Wuxi Second People’s Hospital, Jiangsu[6] Hospital for skin diseases, Institute of Dermatology, Chinese Academy of medical sciences, Nanjing[7] Beijing Friendship Hospital, Capital Medical University, Beijing[8] Huashan Hospital, Fudan University, Shanghai[9] Shanghai Skin Disease Hospital, Shanghai[10]The Southwest Hospital of AMU, Chongqing[11]Peking University First Hospital, Beijing[12]Jinan Central Hospital, Jinan[13]Peking University Third Hospital, Beijing[14]University of Hong Kong-Shenzhen Hospital, Shenzhen[15]Changhai Hospital of Shanghai, Shanghai[16]Ningbo No.2 Hospital, Ningbo[17]The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an[18]Tianjin Medical University General Hospital, Tianjin[19]Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai[20]Yancheng No.1 People’s Hospital, Yancheng[21]The First People’s Hospital of Lianyungang, Lianyungang[22]Beijing Tongren Hospital, CMU, Beijing首都医科大学附属同仁医院[23]Second Affiliated Hospital of Kunming Medical University, Kunming[24]The First Hospital of Jilin University, Changchun[25]Shengjing Hospital of China Medical University, Shenyang中国医科大学附属盛京医院[26]The People’s Hospital of Liaoning Province, Shenyang,[27]The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou[28]Research &Development, Sanofi[29]Medical, Sanofi China, Shanghai, China
第一作者单位:[1]Peking University People’s Hospital, Beijing
推荐引用方式(GB/T 7714):
Zhao Yan,Wu Liming,Lu Qianjin,et al.LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDY[J].ACTA DERMATO-VENEREOLOGICA.2021,101:58-59.
APA:
Zhao, Yan,Wu, Liming,Lu, Qianjin,Gao, Xinghua,Zhu, Xiaohong...&Zhang, Jianzhong.(2021).LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDY.ACTA DERMATO-VENEREOLOGICA,101,
MLA:
Zhao, Yan,et al."LABORATORY SAFETY OF DUPILUMAB AND ITS EFFECT ON INFLAMMATORY BIOMARKERS IN ADULT CHINESE PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: AN ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND PHASE III STUDY".ACTA DERMATO-VENEREOLOGICA 101.(2021):58-59